# BioSpectra, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/biospectra-inc/ffb13a38-4f04-49cb-a6fe-fd55f544fcf0

> Inspection records and compliance data for BioSpectra, Inc. in Bangor, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: BioSpectra, Inc.
- FEI Number: 3010476065
- City: Bangor
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 100 Majestic Way
- Zip Code: 18013
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1232448 - BioSpectra, Inc. - 2024-02-02](https://www.keypedia.com/records/fda_inspections/biospectra-inc/c09d7508-4be4-4e49-b135-4b52cd703b64) — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2024
- [FDA Inspection 1232448 - BioSpectra, Inc. - 2024-02-02](https://www.keypedia.com/records/fda_inspections/biospectra-inc/f7f20e74-376a-4b92-9934-867dde25da63) — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2024
- [EIR - BioSpectra, Inc. - 2021-05-04](https://www.keypedia.com/records/eir/biospectra-inc/ebf38c05-5afa-4d4c-99f7-602f27050a6f) — source: FDA, date: May 4, 2021
- [FDA Inspection 1142678 - BioSpectra, Inc. - 2021-05-04](https://www.keypedia.com/records/fda_inspections/biospectra-inc/a3345fb4-fdbc-4b63-915b-2f6e736d4bf6) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2021
- [EIR - BioSpectra, Inc. - 2017-08-01](https://www.keypedia.com/records/eir/biospectra-inc/74bdd76d-17fc-40c3-b7d7-9d483faa4ca9) — source: FDA, date: August 1, 2017
- [FDA Inspection 1021136 - BioSpectra, Inc. - 2017-08-01](https://www.keypedia.com/records/fda_inspections/biospectra-inc/c9c09085-d24b-4a4a-9a46-4801c63fbbef) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2017
- [FDA Inspection 1021136 - BioSpectra, Inc. - 2017-08-01](https://www.keypedia.com/records/fda_inspections/biospectra-inc/57bfaa14-12ff-4c7f-a1a9-09d8da7a2c99) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2017
- [EIR - BioSpectra, Inc. - 2016-01-29](https://www.keypedia.com/records/eir/biospectra-inc/45876093-300e-4f9b-a60d-5f157b37e4fa) — source: FDA, date: January 29, 2016
- [FDA Inspection 957613 - BioSpectra, Inc. - 2016-01-29](https://www.keypedia.com/records/fda_inspections/biospectra-inc/f40e313b-47b1-42c9-ba08-ca564d6c2729) — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2016
- [FDA Inspection 957613 - BioSpectra, Inc. - 2016-01-29](https://www.keypedia.com/records/fda_inspections/biospectra-inc/03a1f8da-d42b-47b2-8ac5-73669e41f0b5) — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2016
- [FDA Inspection 957613 - BioSpectra, Inc. - 2016-01-29](https://www.keypedia.com/records/fda_inspections/biospectra-inc/e0bd741d-48c1-4a66-b2fa-4b2e4250ae56) — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2016
- [FDA Inspection 916696 - BioSpectra, Inc. - 2015-03-05](https://www.keypedia.com/records/fda_inspections/biospectra-inc/bb56058b-2f13-4eeb-bf18-99d53d3719ec) — classification: Official Action Indicated (OAI), source: FDA, date: March 5, 2015
- [FDA Inspection 916696 - BioSpectra, Inc. - 2015-03-05](https://www.keypedia.com/records/fda_inspections/biospectra-inc/2dc7f88d-d877-467c-8fe3-869d13a2fa0f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 5, 2015

## Related Companies

- [Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jiuzhou-pharmaceutical-co-ltd/6ff21ff3-4c18-4e07-9c38-79e499bfb8fa)
- [Reliable Biopharmaceutical LLC](https://www.keypedia.com/companies/reliable-biopharmaceutical-llc/c2c29fa4-55fa-4f4e-9da7-622d595d395b)
- [Janssen Biologics B.V.](https://www.keypedia.com/companies/janssen-biologics-bv/2e04e15b-1d3c-493d-b2d0-dcbc2108639b)
- [Amphastar Nanjing Pharmaceuticals Inc](https://www.keypedia.com/companies/amphastar-nanjing-pharmaceuticals-inc/ad29710e-4137-4608-933e-8292394dcbc7)
- [Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/c050e25d-d3f2-41d0-a3e6-cd706dc4c417)
- [Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co., LTD.](https://www.keypedia.com/companies/hangzhou-huadong-medicine-group-zhejiang-huayi-pharmaceutical-co-ltd/4fcabfd2-d6e5-41ab-a543-fd9b939f8430)
- [Pfizer Ireland Pharmaceuticals Unlimited Company](https://www.keypedia.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/84fcaae1-7fef-485d-9c60-e561cce3edf7)
- [Juzen Chemical Corporation](https://www.keypedia.com/companies/juzen-chemical-corporation/f0144252-c4b5-4348-8215-996006285286)
- [Tianjin Tianyao Pharmaceuticals Co., Ltd.](https://www.keypedia.com/companies/tianjin-tianyao-pharmaceuticals-co-ltd/d4f41727-1d13-4054-8646-36d9aa8633a6)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/3a9656ad-737b-4682-9ab3-951b1041002e)

## Related Officers

- [James M. Mason](https://www.keypedia.com/people/james-m-mason/a9f601a9-5d81-4386-90dc-80466edb5880)
- [Consumer Safety Officer/ORA/OMPTO/TOS](https://www.keypedia.com/people/niketa-patel/73efe456-da61-4345-8dec-7147b12b88d1)
- [company_representative](https://www.keypedia.com/people/crystal-hambelburg/12918702-556c-464d-bdc9-c8820462bbae)
- [company_representative](https://www.keypedia.com/people/mark-uhlig/2d884960-a8dc-4e15-acea-f71aa3705c2d)